BUY Sun Pharmaceutical Industries Ltd. — ICICI Securities

Entry₹1,685.9Inferred
Target₹1,965
Total upside +16.55% (call closed)
Stop lossNot given
Exit₹1,96521 Jul 2026, 12:07 pm
Target hit+16.55%0.00%upside left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Jul 2026
7 supporting3 neutral1 opposing
Supports the BUY call (7)

Sun Pharmaceutical Industries rises Monday, outperforms competitors

NewsGoogle News·20 Jul · today

(opens in new tab)

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · 6d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·13 Jul · 1w ago

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·23 Jun · 4w ago

Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.